Gil Price

Overview

Gil Price received an average of $513K in total compensation, including $161K in salary, at NeuroBo Pharmaceuticals from 2021 to 2023.

Source: SEC filings on April 30, 2024 and November 28, 2022.

Related executives

We found 13 more executives who work or worked at NeuroBo Pharmaceuticals.

Hyung Kim

NeuroBo Pharmaceuticals

Chief Executive Officer

Joseph Hooker

NeuroBo Pharmaceuticals

Chief Executive Officer

Marshall Woodworth

NeuroBo Pharmaceuticals

Chief Financial Officer

Ben Price

NeuroBo Pharmaceuticals

Chief Executive Officer

Richard Kang

NeuroBo Pharmaceuticals

Chief Executive Officer

Akash Bakshi

NeuroBo Pharmaceuticals

Chief Operating Officer

Mark Versavel

NeuroBo Pharmaceuticals

Chief Medical Officer

Nicola Shannon

NeuroBo Pharmaceuticals

Former Vice President, Clinical Operations

News

You may also like